Gender dysphoria (DSM-5-TR) and gender incongruence (ICD-11)
Gender dysphoria is the DSM-5-TR diagnosis for distress that comes with a marked mismatch between the gender a person experiences and the sex they were assigned at birth. Adolescents and adults need at least six months of that mismatch, shown in at least two of six ways, such as a strong wish to be rid of one’s sex characteristics or to be treated as another gender, along with clinically significant distress or impairment. Children need six of eight, one of them a strong wish to be, or an insistence that they are, another gender. ICD-11 calls it gender incongruence and defines it by a marked and persistent mismatch, lasting about two years in children. The APA states that gender nonconformity is not in itself a mental disorder, and ICD-11 says that in children gender-variant behavior and preferences alone are no basis for the diagnosis.
What drives it
The two manuals put the weight in different places: DSM-5-TR names the distress, ICD-11 names the mismatch. The APA’s DSM-5 fact sheet also notes a practical reason for keeping a diagnosis, since insurance cover for treatment needs one. For identification the useful line runs between identity and distress. A person can be transgender or gender nonconforming with little or no dysphoria, and where distress is present it can sit in the body, in how other people treat them, or in both.
How it shows
Work
Dreading the staff photo or a uniform cut for one sex. Freezing when a manager uses an old name in front of a client. Spending effort every day on voice, clothes or which bathroom to use, and having less left for the job.
Relationships
Pulling back from touch, or from being seen undressed by a partner. Skipping the beach, the gym changing room or the family photo. Relief, sometimes tears, the first time a friend uses the new name without a reminder.
Self
Notice which moments bring the mismatch up: a mirror, your voice on a recording, being called ‘sir’ or ‘ma’am’, a change in your body. Notice whether the discomfort is about the body, about how others see you, or both.
What tells it apart
Body dysmorphic disorder: Body dysmorphic disorder fixes on a flaw others can’t see or think minor, such as a nose or skin, checked and hidden over and over. Gender dysphoria centers on sex characteristics that don’t match the gender a person experiences, and is more likely the fit when the wish is to be seen as another gender, beyond fixing one feature.
Gender minority stress and resilience (Testa): Some of the distress transgender people report comes from rejection, harassment and being misgendered, and in the Mexico City field study those experiences predicted distress strongly. When the pain eases in accepting company and returns with each hostile remark, minority stress may be carrying much of it.
Social anxiety: Social anxiety brings fear of being judged across many settings. When the fear is tied mainly to being read as the assigned gender, in a changing room or on the phone, dysphoria may fit better, and the two can occur together.
A test
Ask the person to describe three recent moments of discomfort and what set each off. A steady pattern over six months or more, tied to sex characteristics or to being seen as the assigned gender, may point to dysphoria, which a clinician experienced in gender can assess.
Questions to carry
- The last time my body or my name felt wrong, what was happening around me?
- Which part of the discomfort is about my body, and which part is about how I am seen?
How strong the research is
clinical. The diagnosis is settled in both manuals. In a field study for ICD-11 (Robles and colleagues, Lancet Psychiatry, 2016), 250 transgender adults at a Mexico City clinic looked back on their adolescence: distress about gender had been common (83%) but not universal, and social rejection and violence strongly predicted distress and difficulty at home, school and work, which the authors read as support for moving the category out of mental disorders. The dispute is over treatment for young people. Systematic reviews from the University of York for the Cass Review (England, April 2024) found a lack of high-quality studies: for puberty blockers no conclusions could be drawn on gender dysphoria or mental health, and bone health and height may be compromised during treatment, while for hormones moderate-quality evidence suggested mental health may improve, with stronger studies still needed. WPATH, whose Standards of Care 8 (2022) include blockers and hormones for some adolescents, calls those standards evidence-based. The American Academy of Pediatrics reaffirmed its 2018 policy in August 2023 and commissioned its own systematic review. McNamara and colleagues (2024, published through Yale Law School) argue the Cass Review held this care to a stricter standard of evidence than many other treatments in children. The dispute is open.
Where it comes from
American Psychiatric Association, DSM-5, 2013, which replaced ‘gender identity disorder’ with ‘gender dysphoria’ and put the weight on distress, kept in DSM-5-TR, 2022. World Health Organization, ICD-11, adopted 2019 and in force from January 2022, which placed ‘gender incongruence’ (HA60 for adolescence and adulthood, HA61 for childhood) in a chapter on conditions related to sexual health, outside mental disorders